Smrithi Rajendiran
Overview
Explore the profile of Smrithi Rajendiran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez Y Baena A, Rajendiran S, Manso B, Krietsch J, Boyer S, Kirschmann J, et al.
Sci Rep
. 2022 Feb;
12(1):3156.
PMID: 35210475
Hematopoietic stem cell (HSC) multipotency and self-renewal are typically defined through serial transplantation experiments. Host conditioning is necessary for robust HSC engraftment, likely by reducing immune-mediated rejection and by clearing...
2.
Rajendiran S, Maji S, Haddad A, Lotan Y, Nandy R, Vishwanatha J, et al.
Front Oncol
. 2021 Apr;
11:628094.
PMID: 33816263
Prostate cancer is one of the leading causes of death despite an astoundingly high survival rate for localized tumors. Though prostate specific antigen (PSA) test, performed in conjunction with digital...
3.
Rajendiran S, Boyer S, Forsberg E
Stem Cell Res
. 2021 Jan;
50:102145.
PMID: 33486300
Hematopoietic stem and progenitor cell (HSPC) transplantation is the paradigm for stem cell therapies. The protocol described here enables quantitative assessment of the body-wide HSPC reconstitution of different mature hematopoietic...
4.
Rajendiran S, Smith-Berdan S, Kunz L, Risolino M, Selleri L, Schroeder T, et al.
Stem Cells
. 2020 May;
38(9):1159-1174.
PMID: 32442338
C-X-C motif chemokine ligand 12 (CXCL12; aka SDF1α) is a major regulator of a number of cellular systems, including hematopoiesis, where it influences hematopoietic cell trafficking, proliferation, and survival during...
5.
Smith-Berdan S, Bercasio A, Rajendiran S, Forsberg E
Stem Cell Reports
. 2019 Oct;
13(5):787-792.
PMID: 31607567
Hematopoietic stem cell (HSC) transplantation is a curative treatment for a variety of blood and immune disorders. Currently available methods to obtain donor HSCs are suboptimal, and the limited supply...
6.
Boyer S, Rajendiran S, Beaudin A, Smith-Berdan S, Muthuswamy P, Perez-Cunningham J, et al.
Stem Cell Reports
. 2019 Mar;
12(4):801-815.
PMID: 30905737
Hematopoiesis is arguably one of the best understood stem cell systems; however, significant challenges remain to reach a consensus understanding of the lineage potential, heterogeneity, and relationships of hematopoietic stem...
7.
Rajendiran S, Gibbs L, Van Treuren T, Klinkebiel D, Vishwanatha J
Oncotarget
. 2016 Sep;
7(40):65307-65319.
PMID: 27589566
Migration and invasion enhancer 1 (MIEN1) is a novel gene involved in prostate cancer progression by enhancing prostate cancer cell migration and invasion. DNA methylation, an important epigenetic regulation, is...
8.
Kpetemey M, Dasgupta S, Rajendiran S, Das S, Gibbs L, Shetty P, et al.
Mol Cancer
. 2015 Aug;
14:156.
PMID: 26272794
Background: Migration and invasion enhancer 1 (MIEN1) is a novel gene found to be abundantly expressed in breast tumor tissues and functions as a critical regulator of tumor cell migration...
9.
Rajendiran S, Kpetemey M, Maji S, Gibbs L, Dasgupta S, Mantsch R, et al.
Cancer Biol Ther
. 2015 May;
16(6):876-85.
PMID: 25996585
Oral squamous cell carcinoma is a highly malignant tumor with the potential to invade local and distant sites and promote lymph node metastasis. Major players underlying the molecular mechanisms behind...
10.
Rajendiran S, Parwani A, Hare R, Dasgupta S, Roby R, Vishwanatha J
Mol Cancer
. 2014 Nov;
13:250.
PMID: 25406943
Background: MicroRNAs (miRNAs) are crucial molecules that regulate gene expression and hence pathways that are key to prostate cancer progression. These non-coding RNAs are highly deregulated in prostate cancer thus...